Related Experiment Video
Updated: Apr 21, 2026
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Optimizing the Clinical Utility of Biomarkers in Oncology: The NCCN Biomarkers Compendium
Marian L Birkeland1, Joan S McClure
1From Compendia Development (Dr Birkeland) and Clinical Information and Publications (Ms McClure), National Comprehensive Cancer Network, NCCN, Fort Washington, Pennsylvania.
Context:
The rapid development of commercial biomarker tests for oncology indications has led to confusion about which tests are clinically indicated for oncology care. By consolidating biomarker testing information recommended within National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines), the NCCN Biomarkers Compendium aims to ensure that patients have access to appropriate biomarker testing based on the evaluations and recommendations of the expert NCCN panel members.
Objectives:
To present the recently launched NCCN Biomarkers Compendium.
Data Sources:
Biomarker testing information recommended within NCCN Clinical Treatment Guidelines as well as published resources for genetic and biological information.
Conclusions:
The NCCN Biomarkers Compendium is a continuously updated resource for clinicians who need access to relevant and succinct information about biomarker testing in oncology and is linked directly to the recommendations provided within the NCCN Clinical Practice Guidelines.
More Related Videos
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023